The correlation between VWF antigen and parameters (BCVA, CRT, and CCT) at baseline.

In each graph, the horizontal axis presents the VWF antigen (%). BCVA, best-corrected visual acuity (LogMAR unit); CRT, central retinal thickness; CCT, central choroidal thickness; RVO, retinal vein occlusion.</p

Correlations between VWF antigen and parameters (BCVA, CRT, and CCT) at 1 month after anti-VEGF treatment.

In each graph, the horizontal axis presents the VWF antigen (%). BCVA, best-corrected visual acuity (LogMAR unit); CRT, central retinal thickness; CCT, central choroidal thickness; RVO, retinal vein occlusion.</p

The correlation between VWF antigen and the CCT of fellow eyes at 1 month after anti-VEGF treatment.

CCT, central choroidal thickness; RVO, retinal vein occlusion.</p

The correlation between VWF antigen and the CCT of fellow eyes at baseline.

CCT, central choroidal thickness; RVO, retinal vein occlusion.</p

Alterations of clinical data in patients with RVO by treatment.

Alterations of clinical data in patients with RVO by treatment.</p

Alterations of VWF antigen after anti-VEGF treatment.

Each of the values above the graph presents the median with the interquartile range. *< 0.05, **< 0.01. RVO, retinal vein occlusion.</p

Alterations of VWF antigen in patients with branch RVO according to the administered drug.

Each of the values above the graph presents the median with the interquartile range. *< 0.05, **< 0.01. RVO, retinal vein occlusion.</p

Basic characteristics of RVO patients and controls.

Basic characteristics of RVO patients and controls.</p

Basic characteristics of patients with RVO classified according to anti-VEGF drugs.

Basic characteristics of patients with RVO classified according to anti-VEGF drugs.</p

Statistical analysis of significance between fiscal years using Ryan’s multiple comparisons for the number of myringotomies performed before and after introduction of the free heptavalent pneumococcal conjugate vaccine.

<p>^# nominal level of significance.</p><p>Statistical analysis of significance between fiscal years using Ryan’s multiple comparisons for the number of myringotomies performed before and after introduction of the free heptavalent pneumococcal conjugate vaccine.</p